Ferenc Tracik
Chief Tech/Sci/R&D Officer bij NEUROSENSE THERAPEUTICS LTD.
Vermogen: 223 771 $ op 31-03-2024
Profiel
Ferenc Tracik's career history includes current and former positions as well as education.
Currently, he is the Chief Medical Officer at Neurosense Therapeutics Ltd.
Previously, he held the position of Managing Director-Germany Specialty Medicines at Teva Pharmaceutical Industries Ltd.
from 2013 to 2017.
From 2017 to 2020, he served as the VP-Medical Europe & Canada at Biogen, Inc. Additionally, he has worked as the Global Head-Medical at Orphazyme A.
In terms of education, Dr. Tracik holds doctorate degrees from Freie Universität Berlin and the University of Regensburg.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-04-2024 | 122 951 ( 0.90% ) | 223 771 $ | 31-03-2024 |
Actieve functies van Ferenc Tracik
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 01-12-2021 |
Eerdere bekende functies van Ferenc Tracik
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-11-2020 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01-04-2017 |
| ORPHAZYME A/S | Corporate Officer/Principal | - |
Opleiding van Ferenc Tracik
| University of Regensburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| ORPHAZYME A/S | Health Technology |
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
